Uncategorised - European Medical Journal

The AI Revolution: London Tech Week 2026

The UK government has launched major investments in AI and plans for workforce transformation at London Tech Week 2026.

Healthcare professional reviewing hepatitis C care cascade data and follow-up RNA testing results.

Missing RNA Tests Skew Hepatitis C Cure Rates

Hepatitis C care cascade measures may underestimate cure when follow-up RNA testing is incomplete among insured U.S. adults.

Patient using an inhaler, representing testosterone treatment and respiratory medication use.

Testosterone Treatment Linked to Lower Steroid Use

Testosterone treatment may alter respiratory medication use in people taking inhaled corticosteroids, new registry data suggest.

Interview with Lord David Gifford Leathes Prior

In terms of both diagnostics and therapeutics, the UK is extremely well positioned in science…

Endometriosis

ESHRE 2026: Mood Changes Drive Low Satisfaction with Hormonal Therapy

Women with endometriosis and adenomyosis report low satisfaction with hormonal therapy, with mood changes emerging as the strongest predictor of dissatisfaction.

AI assisted skin analysis on a smartphone for intelligent psoriasis research and digital dermatology.

Intelligent Psoriasis Research Suggests New Care Model

Intelligent psoriasis research is accelerating precision diagnosis, personalized treatment, and long term management across dermatology.

Physician discussing nutrition and scurvy risk with adult patient in clinical consultation.

Scurvy Linked to Unusual Joint Bleeding

Scurvy can present with hemarthrosis and musculoskeletal symptoms that closely mimic inflammatory rheumatologic disease.

NHS App to Launch New AI Triage Tool

The NHS App is set to launch a new AI triage tool, designed to cut waiting times and improve patient care.

IVF add-ons

Evidence Behind IVF Add-Ons Deemed Insubstantial and Poor

New research has found that evidence behind the effectiveness of IVF treatment add-ons is poor.

EHA Lifetime Achievement 2026 Awardee: Claire Harrison

Before the advent of JAK inhibitors, we did not have any effective therapy for patients with myelofibrosis. We could offer them a…